These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 15907807
1. Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by Vildagliptin ((2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}-pyrrolidine-2-carbonitrile). Brandt I, Joossens J, Chen X, Maes MB, Scharpé S, De Meester I, Lambeir AM. Biochem Pharmacol; 2005 Jul 01; 70(1):134-43. PubMed ID: 15907807 [Abstract] [Full Text] [Related]
2. 7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one is a novel competitive and selective inhibitor of dipeptidyl peptidase IV with an antihyperglycemic activity. Yamazaki K, Yasuda N, Inoue T, Nagakura T, Kira K, Shinoda M, Saeki T, Tanaka I. J Pharmacol Exp Ther; 2006 Dec 01; 319(3):1253-7. PubMed ID: 16980568 [Abstract] [Full Text] [Related]
3. 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. Villhauer EB, Brinkman JA, Naderi GB, Burkey BF, Dunning BE, Prasad K, Mangold BL, Russell ME, Hughes TE. J Med Chem; 2003 Jun 19; 46(13):2774-89. PubMed ID: 12801240 [Abstract] [Full Text] [Related]
4. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor. Tajima A, Yamamoto K, Kozakai A, Okumura-Kitajima L, Mita Y, Kitano K, Jingu S, Nakaike S. Eur J Pharmacol; 2011 Mar 25; 655(1-3):99-107. PubMed ID: 21262219 [Abstract] [Full Text] [Related]
5. From the bench to the bedside: dipeptidyl peptidase IV inhibitors, a new class of oral antihyperglycemic agents. Pei Z. Curr Opin Drug Discov Devel; 2008 Jul 25; 11(4):512-32. PubMed ID: 18600568 [Abstract] [Full Text] [Related]
6. ASP4000, a slow-binding dipeptidyl peptidase 4 inhibitor, has antihyperglycemic activity of long duration in Zucker fatty rats. Tanaka-Amino K, Matsumoto K, Hatakeyama Y, Takakura S, Mutoh S. Acta Diabetol; 2010 Mar 25; 47(1):43-8. PubMed ID: 19238312 [Abstract] [Full Text] [Related]
7. The role of vildagliptin in the management of type 2 diabetes mellitus. Kleppinger EL, Helms K. Ann Pharmacother; 2007 May 25; 41(5):824-32. PubMed ID: 17456545 [Abstract] [Full Text] [Related]
8. (2S,4S)-1-[2-(1,1-dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV. Yeh TK, Tsai TY, Hsu T, Cheng JH, Chen X, Song JS, Shy HS, Chiou MC, Chien CH, Tseng YJ, Huang CY, Yeh KC, Huang YL, Huang CH, Huang YW, Wang MH, Tang HK, Chao YS, Chen CT, Jiaang WT. Bioorg Med Chem Lett; 2010 Jun 15; 20(12):3596-600. PubMed ID: 20483603 [Abstract] [Full Text] [Related]
9. Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats. Burkey BF, Li X, Bolognese L, Balkan B, Mone M, Russell M, Hughes TE, Wang PR. J Pharmacol Exp Ther; 2005 Nov 15; 315(2):688-95. PubMed ID: 16027230 [Abstract] [Full Text] [Related]
10. Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. Kirby M, Yu DM, O'Connor S, Gorrell MD. Clin Sci (Lond); 2009 Sep 28; 118(1):31-41. PubMed ID: 19780719 [Abstract] [Full Text] [Related]
11. ASP8497 is a novel selective and competitive dipeptidyl peptidase-IV inhibitor with antihyperglycemic activity. Matsuyama-Yokono A, Tahara A, Nakano R, Someya Y, Nagase I, Hayakawa M, Shibasaki M. Biochem Pharmacol; 2008 Jul 01; 76(1):98-107. PubMed ID: 18468582 [Abstract] [Full Text] [Related]
12. Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin. Taldone T, Zito SW, Talele TT. Bioorg Med Chem Lett; 2008 Jan 15; 18(2):479-84. PubMed ID: 18068977 [Abstract] [Full Text] [Related]
13. Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors. Zhao G, Taunk PC, Magnin DR, Simpkins LM, Robl JA, Wang A, Robertson JG, Marcinkeviciene J, Sitkoff DF, Parker RA, Kirby MS, Hamann LG. Bioorg Med Chem Lett; 2005 Sep 15; 15(18):3992-5. PubMed ID: 16046120 [Abstract] [Full Text] [Related]
14. K579, a slow-binding inhibitor of dipeptidyl peptidase IV, is a long-acting hypoglycemic agent. Takasaki K, Iwase M, Nakajima T, Ueno K, Nomoto Y, Nakanishi S, Higo K. Eur J Pharmacol; 2004 Feb 23; 486(3):335-42. PubMed ID: 14985056 [Abstract] [Full Text] [Related]
15. Selectivity among dipeptidyl peptidases of the S9b family. Bjelke JR, Kanstrup AB, Rasmussen HB. Cell Mol Biol (Noisy-le-grand); 2006 Dec 31; 52(4):3-7. PubMed ID: 17543192 [Abstract] [Full Text] [Related]
16. Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetes. Del Prato S. Int J Clin Pract Suppl; 2007 Aug 31; (154):38-48. PubMed ID: 17593276 [Abstract] [Full Text] [Related]
17. Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 diabetes mellitus. Langley AK, Suffoletta TJ, Jennings HR. Pharmacotherapy; 2007 Aug 31; 27(8):1163-80. PubMed ID: 17655515 [Abstract] [Full Text] [Related]
18. The islet enhancer vildagliptin: mechanisms of improved glucose metabolism. Ahrén B, Foley JE. Int J Clin Pract Suppl; 2008 Mar 31; (159):8-14. PubMed ID: 18269436 [Abstract] [Full Text] [Related]
19. 3-[2-((2S)-2-cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes. Coumar MS, Chang CN, Chen CT, Chen X, Chien CH, Tsai TY, Cheng JH, Wu HY, Han CH, Wu SH, Huang YW, Hsu T, Hsu LJ, Chao YS, Hsieh HP, Jiaang WT. Bioorg Med Chem Lett; 2007 Mar 01; 17(5):1274-9. PubMed ID: 17194587 [Abstract] [Full Text] [Related]
20. DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide. Ahrén B, Winzell MS, Wierup N, Sundler F, Burkey B, Hughes TE. Regul Pept; 2007 Oct 04; 143(1-3):97-103. PubMed ID: 17482289 [Abstract] [Full Text] [Related] Page: [Next] [New Search]